Clin Colon Rectal Surg 2024; 37(03): 127-132
DOI: 10.1055/s-0043-1770380
Review Article

The Natural History of Hereditary Colorectal Cancer Syndromes: From Phenotype to Genotype? Where Do We Stand and What Does the Future Hold?

James Church
1   Division of Colorectal Surgery, Department of Surgery, Columbia University Medical Center, New York, New York
› Author Affiliations
Funding None.

Abstract

Applying the concept of a “natural history” to hereditary colorectal cancer is an interesting exercise because the way the syndromes are approached has changed so drastically. However, the exercise is instructive as it forces us to think in depth about where we are, where we have been, and, most helpfully, about where we may be going. In this article the diagnosis, along with endoscopic and surgical management of hereditary colorectal cancer are discussed in the context of their history and the changes in genomics and technology that have occurred over the last one hundred years.



Publication History

Article published online:
09 August 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Richter FC. Remembering Johann Gregor Mendel: a human, a Catholic priest, an Augustinian monk, and abbot. Mol Genet Genomic Med 2015; 3 (06) 483-485
  • 2 Morgan SG. How theories became knowledge: Morgan’s chromosome theory of heredity in America and Britain. J Hist Biol 2002; 35 (03) 471-535
  • 3 Johannsen WL. The Genotype Conception of Heredity. Am Nat 1911; 45: 129-159
  • 4 Miescher F. “Ueber die chemische Zusammensetzung der Eiterzellen” (On the chemical composition of pus cells). Medicinisch-chemische Untersuchungen 1871; 4: 441-460
  • 5 Jones ME. Albrecht Kossel, a biographical sketch. Yale J Biol Med 1953; 26 (01) 80-97
  • 6 Flemming W. “Zur Kenntniss der Zelle und ihrer Theilungs-Erscheinungen” (PDF). Schriften des Naturwissenschaftlichen Vereins für Schleswig-Holstein. 1878; 3: 23-27
  • 7 Cobb M. A speculative history of DNA: what if Oswald Avery had died in 1934?. PLoS Biol 2016; 14 (12) e2001197
  • 8 Endersby J. Mutant utopias: evening primroses and imagined futures in early twentieth-century America. Isis 2013; 104 (03) 471-503
  • 9 Watson JD, Crick FHC. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 1953; 171 (4356): 737-738
  • 10 Nirenberg MW, Matthaei JH. The dependence of cell-free protein synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides. Proc Natl Acad Sci U S A 1961; 47 (10) 1588-1602
  • 11 Heather JM, Chain B. The sequence of sequencers: the history of sequencing DNA. Genomics 2016; 107 (01) 1-8
  • 12 Sanger F, Coulson AR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 1975; 94 (03) 441-448
  • 13 Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology 2013; 38 (01) 23-38
  • 14 Mullis KB. The unusual origin of the polymerase chain reaction. Sci Am 1990; 262 (04) 56-61 , 64–65
  • 15 Behjati S, Tarpey PS. What is next generation sequencing?. Arch Dis Child Educ Pract Ed 2013; 98 (06) 236-238
  • 16 Bishop JE, Waldholz M. Genome: The Story of the Most Astonishing Scientific Adventure of Our Time–the Attempt to Map All the Genes in the Human Body. New York: Simon and Schuster; 1990: 201
  • 17 Hydbring P, Badalian-Very G. Clinical applications of microRNAs. F1000 Res 2013; 2: 136
  • 18 Uffelmann E, Huang QQ, Munung NS. et al. Genome-wide association studies. Nat Rev Methods Primers 2021; 1: 59
  • 19 Wang Q, Peng WX, Wang L, Ye L. Toward multiomics-based next-generation diagnostics for precision medicine. Per Med 2019; 16 (02) 157-170
  • 20 Pray L. Transposons: the jumping genes. Nature Education 2008; 1 (01) 204
  • 21 Takahashi K. Cellular reprogramming. Cold Spring Harb Perspect Biol 2014; 6 (02) a018606
  • 22 Wirth T, Parker N, Ylä-Herttuala S. History of gene therapy. Gene 2013; 525 (02) 162-169
  • 23 Bülow S, Berk T, Neale K. The history of familial adenomatous polyposis. Fam Cancer 2006; 5 (03) 213-220
  • 24 Warthin A. Heredity with reference to carcinoma: as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895–1913. Arch Intern Med 1913; 12 (05) 546-555
  • 25 Kinzler KW, Nilbert MC, Su LK. et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253 (5020): 661-665
  • 26 Boland CR, Lynch HT. The history of Lynch syndrome. Fam Cancer 2013; 12 (02) 145-157
  • 27 Keller JJ, Offerhaus GJ, Giardiello FM, Menko FH. Jan Peutz, Harold Jeghers and a remarkable combination of polyposis and pigmentation of the skin and mucous membranes. Fam Cancer 2001; 1 (3-4): 181-185
  • 28 Horrilleno EG, Eckert C, Ackerman LV. Polyps of the rectum and colon in children. Cancer 1957; 10 (06) 1210-1220
  • 29 Lloyd II KM, Dennis M. Cowden's disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 1963; 58 (01) 136-142
  • 30 Fishel R, Lescoe MK, Rao MR. et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75 (05) 1027-1038
  • 31 Bronner CE, Baker SM, Morrison PT. et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368 (6468): 258-261
  • 32 Nicolaides NC, Papadopoulos N, Liu B. et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371 (6492): 75-80
  • 33 Miyaki M, Konishi M, Tanaka K. et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997; 17 (03) 271-272
  • 34 Hemminki A, Markie D, Tomlinson I. et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391 (6663): 184-187
  • 35 Howe JR, Roth S, Ringold JC. et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998; 280 (5366): 1086-1088
  • 36 Howe JR, Bair JL, Sayed MG. et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 2001; 28 (02) 184-187
  • 37 Liaw D, Marsh DJ, Li J. et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997; 16 (01) 64-67
  • 38 Al-Tassan N, Chmiel NH, Maynard J. et al. Inherited variants of MYH associated with somatic G:C–>T:A mutations in colorectal tumors. Nat Genet 2002; 30 (02) 227-232
  • 39 Church J, Kravochuck S. The “studded” rectum: phenotypic evidence of MYH-associated polyposis. Dis Colon Rectum 2016; 59 (06) 565-569
  • 40 Palles C, Cazier JB, Howarth KM. et al; CORGI Consortium, WGS500 Consortium. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 2013; 45 (02) 136-144
  • 41 Weren RD, Ligtenberg MJ, Kets CM. et al. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet 2015; 47 (06) 668-671
  • 42 Adam R, Spier I, Zhao B. et al. Exome sequencing identifies biallelic MSH3 germline mutations as a recessive subtype of colorectal adenomatous polyposis. Am J Hum Genet 2016; 99 (02) 337-351
  • 43 Jaeger E, Leedham S, Lewis A. et al; HMPS Collaboration. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet 2012; 44 (06) 699-703
  • 44 Liang J, Church J. How to manage the patient with early-age-of-onset (<50 years) colorectal cancer?. Surg Oncol Clin N Am 2010; 19 (04) 725-731
  • 45 Segev L, Kalady MF, Church JM. Left-sided dominance of early-onset colorectal cancers: a rationale for screening flexible sigmoidoscopy in the young. Dis Colon Rectum 2018; 61 (08) 897-902
  • 46 Chouhan H, Ferrandon S, DeVecchio J, Kalady MF, Church JM. A changing spectrum of colorectal cancer biology with age: implications for the young patient. Dis Colon Rectum 2019; 62 (01) 21-26
  • 47 Melson J. The pathway to monitoring quality of care for patients with adenomatous oligopolyposis of unknown etiology. Endoscopy 2022; 54 (07) 698-699
  • 48 Patel SG, Murphy CC, Lieu CH, Hampel H. Early age onset colorectal cancer. Adv Cancer Res 2021; 151: 1-37
  • 49 Muller C, Yamada A, Ikegami S. et al. Risk of colorectal cancer in serrated polyposis syndrome: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2022; 20 (03) 622-630.e7
  • 50 Ünlü M, Uzun E, Bengi G, Sağol Ö, Sarıoğlu S. Molecular characteristics of colorectal hyperplastic polyp subgroups. Turk J Gastroenterol 2020; 31 (08) 573-580
  • 51 Rex DK, Ahnen DJ, Baron JA. et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012; 107 (09) 1315-1329 , quiz 1314, 1330
  • 52 Cauley CE, Hassab TH, Feinberg A, Church J. Sessile serrated polyposis: not an inherited syndrome?. Dis Colon Rectum 2020; 63 (02) 183-189
  • 53 Buchanan DD, Clendenning M, Zhuoer L. et al; Genetics of Colonic Polyposis Study. Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study. Gut 2017; 66 (06) 1170-1172
  • 54 Sarkozy A, Carta C, Moretti S. et al. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat 2009; 30 (04) 695-702
  • 55 Dekker E, Bleijenberg A, Balaguer F. Dutch-Spanish-British Serrated Polyposis Syndrome collaboration. Update on the World Health Organization criteria for diagnosis of serrated polyposis syndrome. Gastroenterology 2020; 158 (06) 1520-1523
  • 56 Samadder NJ, Riegert-Johnson D, Boardman L. et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol 2021; 7 (02) 230-237
  • 57 Hampel H. Population screening for hereditary colorectal cancer. Surg Oncol Clin N Am 2018; 27 (02) 319-325
  • 58 Bülow S, Burn J, Neale K, Northover J, Vasen H. The establishment of a polyposis register. Int J Colorectal Dis 1993; 8 (01) 34-38
  • 59 Church J, Kiringoda R, LaGuardia L. Inherited colorectal cancer registries in the United States. Dis Colon Rectum 2004; 47 (05) 674-678
  • 60 Patch C, Middleton A. Genetic counselling in the era of genomic medicine. Br Med Bull 2018; 126 (01) 27-36
  • 61 Corson VL, Bernhardt BA. The evolution of genetic counseling at Johns Hopkins Hospital and beyond. Am J Med Genet A 2021; 185 (11) 3230-3235
  • 62 Campbell IS, Howell JD, Evans HH. Visceral vistas: Basil Hirschowitz and the birth of fiberoptic endoscopy. Ann Intern Med 2016; 165 (03) 214-218
  • 63 Neale K, Bülow S. Leeds Castle Polyposis Group. Origins of the Leeds Castle Polyposis Group. Fam Cancer 2003; 2 (Suppl. 01) 1-2
  • 64 Church J, Lowry A, Simmang C. Standards Task Force, American Society of Colon and Rectal Surgeons. Practice parameters for the identification and testing of patients at risk for dominantly inherited colorectal cancer–supporting documentation. Dis Colon Rectum 2001; 44 (10) 1404-1412